Anthony, A, Sim, R, Guillaume, JL, Strosberg, AD, Dhillon, AP, Pounder, RE, Wakefield, AJ 2000. Beta-3 adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. Alimentary Pharmacology and Therapeutics 14, 579–585.
Arch, JR 2008. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta-3 adrenoceptor agonists. Naunyn-Schmiedeberg’s Archives of Pharmacology 378, 225–240.
Berkowitz, DE, Nardone, NA, Smiley, RM, Price, DT, Kreutter, DK, Fremeau, RT, Schwinn, DA 1995. Distribution of beta-3 adrenoceptor mRNA in human tissues. European Journal of Pharmacology 289, 223–228.
Cannon, B, Nedergaard, J 2004. Brown adipose tissue: function and physiological significance. Physiological Reviews 84, 277–359.
Carron, J, Morel, C, Hammon, HM, Blum, JW 2005. Ontogenetic development of mRNA levels and binding sites of hepatic beta-adrenergic receptors in cattle. Domestic Animal Endocrinology 28, 320–330.
Chamberlain, PD, Jennings, KH, Paul, F, Cordell, J, Berry, A, Holmes, SD, Park, J, Chambers, J, Sennitt, MV, Stock, MJ, Cawthorne, MA, Young, PW, Murphy, GJ 1999. The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: direct evidence of the b3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. International Journal of Obesity 23, 1057–1065.
Cheng, HJ, Zhang, ZS, Onishi, K, Ukai, T, Sane, DC, Cheng, CP 2001. Upregulation of functional β3-adrenergic receptor in the failing canine myocardium. Circulation Research 89, 599–606.
De Matteis, R, Arch, JRS, Petroni, ML, Ferrari, D, Cinti, S, Stock, MJ 2002. Immunohistochemical identification of the β3-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. International Journal of Obesity 26, 1442–1450.
Evans, BA, Papaioannou, M, Bonazzi, VR, Summers, RJ 1996. Expression of beta 3-adrenoceptor mRNA in rat tissues. British Journal of Pharmacology 117, 210–216.
Igawa, Y, Yamazaki, Y, Takeda, H, Hayakawa, K, Akahane, M, Ajisawa, Y, Yoneyama, T, Nishizawa, O, Andersson, KE 1999. Functional and molecular biological evidence for a possible beta 3-adrenoceptor in the human detrusor muscle. British Journal of Pharmacology 126, 819–825.
Inderwies, T, Pfaffl, MW, Meyer, HH, Blum, JW, Bruckmaier, RM 2003. Detection and quantification of mRNA expression of alpha- and beta-adrenergic receptor subtypes in the mammary gland of dairy cows. Domestic Animal Endocrinology 24, 123–135.
Kobel, B, Engel, L, Ontsouka, EC, Graber, HU, Blum, JW, Steiner, A, Meylan, M 2006. Quantitative mRNA analysis of adrenergic receptor subtypes in the intestines of healthy dairy cows and dairy cows with cecal dilatation-dislocation. American Journal of Veterinary Research 67, 1367–1376.
Krief, S, Lönnqvist, F, Raimbault, S, Baude, B, Van Spronsen, A, Arner, P, Strosberg, AD, Ricquier, D, Emorine, LJ 1993. Tissue distribution of Beta 3-adrenergic receptor mRNA in man. The Journal of Clinical Investigation 91, 344–349.
Larsen, TM, Toubro, S, van Baak, MA, Gottesdiener, KM, Larson, P, Saris, WHM, Astrup, A 2002. Effect of a 28-d treatment with L-796568, a novel beta3-adrenergic receptor agonist, on energy expenditure and body composition in obese men. American Journal of Clinical Nutrition 76, 780–788.
Matos, LL, Stabenow, E, Tavares, MR, Ferraz, AR, Capelozzi, VL, Pinhal, MA 2006. Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics 61, 417–424.
McNeel, RL, Mersmann, HJ 1995. β3-adrenergic receptor subtypes transcripts in porcine adipose tissues. Journal of Animal Science 73, 1962–1971.
McNeel, RL, Mersmann, HJ 1999. Distribution and quantification of beta1-, beta2-, and beta3-adrenergic receptor subtype transcripts in porcine tissues. Journal of Animal Science 77, 611–621.
Meylan, M, Georgieva, TM, Reist, M, Blum, JW, Martig, J, Georgiev, IP, Steiner, A 2004. Distribution of mRNA that codes for subtypes of adrenergic receptors in the gastrointestinal tract of dairy cows. American Journal of Veterinary Research 65, 1142–1150.
Moniotte, S, Kobzik, L, Feron, O, Trochu, JN, Gauthier, C, Balligand, JL 2001. Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103, 1649–1655.
Morimoto, A, Hasegawa, H, Cheng, HJ, Little, WC, Cheng, CP 2004. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. American Journal of Physiology Heart and Circulatory Physiology 286, H2425–H2433.
Pietri-Rouxel, F, Lenzen, G, Kapoor, A, Drumare, MF, Archimbault, P, Strosberg, AD, Manning, BSJ 1995. Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor. European Journal of Biochemistry 230, 350–358.
Rodriguez, M, Carillon, C, Coquerel, A, Le Fur, G, Ferrara, P, Caput, D, Shire, D 1995. Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain. Brain Research. Molecular Brain Research 29, 369–375.
Rouget, C, Barthez, O, Goirand, F, Leroy, MJ, Breuiller-Fouché, M, Rakotoniaina, Z, Guérard, P, Morcillo, EJ, Advenier, C, Sagot, P, Cabrol, D, Dumas, M, Bardou, M 2006. Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia. Biology of Reproduction 74, 209–216.
Rozec, B, Gauthier, C 2006. Beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacology and Therapeutics 111, 652–673.
Rozec, B, Serpillon, S, Toumaniantz, G, Sèze, C, Rautureau, Y, Baron, O, Noireaud, J, Gauthier, C 2005. Characterization of beta3-Adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management. Journal of the American College of Cardiology 46, 351–359.
Sasaki, N, Uchida, E, Niiyama, M, Yoshida, T, Saito, M 1998a. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs. I. The presence of Canine β3-adrenergic receptor and in vivo lipomolibization by its agonists. The Journal of Veterinary Medical Science 60, 459–463.
Sasaki, N, Uchida, E, Niiyama, M, Yoshida, T, Saito, M 1998b. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs. II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a β3-adrenergic agonist. The Journal of Veterinary Medical Science 60, 465–469.
Sheridan, R, Ferreira, AV, Hoffman, LC 2003. Production efficiency of South African Mutton Merino lambs and Boer goat kids receiving either a low or a high energy feedlot diet. Small Ruminant Research 50, 75–82.
Skeberdis, VA, Gendviliene, V, Zablockaite, D, Treinys, R, Macianskiene, R, Bogdelis, A, Jurevicius, J, Fischmeister, R 2008. β3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. The Journal of Clinical Investigation 118, 3219–3227.
Strosberg, AD 1997. Structure and function of the beta 3-adrenergic receptor. Annual Review of Pharmacology and Toxicology 37, 421–450.
Sumner, JM, McNamara, JP 2007. Expression of lipolytic genes in the adipose tissues of pregnant and lactating holstein cattle. Journal of Dairy Science 90, 5237–5246.
Trebicka, J, Hennenberg, M, Schulze Pröbsting, A, Laleman, W, Klein, S, Granzow, M, Nevens, F, Zaagsma, J, Heller, J, Sauerbruch, T 2009. Role of beta(3)-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis. Hepatology 50, 1–12.
Van Baak, MA, Hul, GB, Toubro, S, Astrup, A, Gottesdiener, KM, DeSmet, M, Saris, WH 2002. Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. Clinical Pharmacology and Therapeutics 71, 272–279.
Weyer, C, Gautier, JF, JrDanforth, E 1999. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes-an update. Diabetes and Metabolism 25, 11–21.